We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BrightSpring's Home Health Arm Soars: What's Powering Growth?
Read MoreHide Full Article
Key Takeaways
BrightSpring posted $178M in Q1 2025 Home Health Care sales, marking 21% year-over-year growth
BrightSpring's growth is driven by Medicare Advantage gains and strong operational execution.
BTSG's daily census rose 12% to 30,000 and 80% of branches earned 4-star ratings or higher.
BrightSpring Health Services, Inc. (BTSG - Free Report) is experiencing strong momentum in its Home Health Care segment, backed by the robust global expansion of the Home Healthcare market. Per a Grand View Research report, the global home healthcare market is estimated to witness a CAGR of 10.21% from 2025 to 2030.
The company’s Home Health Care segment generated $178 million in sales in the first quarter of 2025, marking a 21% year-over-year increase. Growth was driven by robust operational execution, expanding Medicare Advantage contracts, high patient satisfaction (approximately 90%), and leading quality metrics (over 80% of branches are rated 4 stars or higher, and the 60-day hospitalization rate continues to decline).
The company’s average daily census across home health and hospice rose to over 30,000, up 12% from the prior year. BrightSpring is also advancing its Homebase Primary Care model, aimed at delivering physician-led services in cost-effective, in-home settings. Additionally, the company is leveraging value-based models like ACOs and SNPs, targeting scalable growth to over 100,000 patients in the coming years. Overall, BrightSpring is capitalizing on the shift toward home-based care, supporting growth as well as improved patient outcomes.
Key Peers of BTSG in the Home Healthcare Space
Cardinal Health’s (CAH - Free Report) at-Home Solutions expands the company’s reach into the home healthcare market, where demand for medical supplies, infusion therapies, and remote patient monitoring is surging. In fiscal 2024, it served over 5 million patients, offering higher-margin, direct-to-patient distribution that complements institutional sales. Recent investments include a new automated distribution center in South Carolina and a second planned for Texas in 2025. The April 2025 acquisition of Advanced Diabetes Supply Group further strengthens Cardinal Health’s at-home capabilities.
Addus HomeCare Corporation’s (ADUS - Free Report) home healthcare segment saw modest growth in the first quarter of 2025, reflecting improved payer rates and operational stability. Though it remains a smaller part of the overall business, home health plays a strategic, integrative role. Addus is cautiously expanding this line through selective M&A while leveraging technology and operational synergies to enhance performance.
BTSG’s Price Performance, Valuation and Estimates
Shares of BrightSpring have gained 98.8% in the past year against the industry’s 18.9% decline. The S&P 500 composite grew 11.8% in the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, BTSG trades at a forward price-to-earnings ratio of 20.32, above the industry’s 14.25.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for BTSG’s earnings has been on the rise over the past 60 days.
Image: Bigstock
BrightSpring's Home Health Arm Soars: What's Powering Growth?
Key Takeaways
BrightSpring Health Services, Inc. (BTSG - Free Report) is experiencing strong momentum in its Home Health Care segment, backed by the robust global expansion of the Home Healthcare market. Per a Grand View Research report, the global home healthcare market is estimated to witness a CAGR of 10.21% from 2025 to 2030.
The company’s Home Health Care segment generated $178 million in sales in the first quarter of 2025, marking a 21% year-over-year increase. Growth was driven by robust operational execution, expanding Medicare Advantage contracts, high patient satisfaction (approximately 90%), and leading quality metrics (over 80% of branches are rated 4 stars or higher, and the 60-day hospitalization rate continues to decline).
The company’s average daily census across home health and hospice rose to over 30,000, up 12% from the prior year. BrightSpring is also advancing its Homebase Primary Care model, aimed at delivering physician-led services in cost-effective, in-home settings. Additionally, the company is leveraging value-based models like ACOs and SNPs, targeting scalable growth to over 100,000 patients in the coming years. Overall, BrightSpring is capitalizing on the shift toward home-based care, supporting growth as well as improved patient outcomes.
Key Peers of BTSG in the Home Healthcare Space
Cardinal Health’s (CAH - Free Report) at-Home Solutions expands the company’s reach into the home healthcare market, where demand for medical supplies, infusion therapies, and remote patient monitoring is surging. In fiscal 2024, it served over 5 million patients, offering higher-margin, direct-to-patient distribution that complements institutional sales. Recent investments include a new automated distribution center in South Carolina and a second planned for Texas in 2025. The April 2025 acquisition of Advanced Diabetes Supply Group further strengthens Cardinal Health’s at-home capabilities.
Addus HomeCare Corporation’s (ADUS - Free Report) home healthcare segment saw modest growth in the first quarter of 2025, reflecting improved payer rates and operational stability. Though it remains a smaller part of the overall business, home health plays a strategic, integrative role. Addus is cautiously expanding this line through selective M&A while leveraging technology and operational synergies to enhance performance.
BTSG’s Price Performance, Valuation and Estimates
Shares of BrightSpring have gained 98.8% in the past year against the industry’s 18.9% decline. The S&P 500 composite grew 11.8% in the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, BTSG trades at a forward price-to-earnings ratio of 20.32, above the industry’s 14.25.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for BTSG’s earnings has been on the rise over the past 60 days.
Image Source: Zacks Investment Research
BTSG stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.